NO983617L - Vaksine mot Varicella Zoster virusgen 63 produkt - Google Patents

Vaksine mot Varicella Zoster virusgen 63 produkt

Info

Publication number: NO983617L
Authority: NO; Norway
Prior art keywords: product; vaccine against; zoster virus; virus gene; varicella zoster
Prior art date: 1996-02-09

Application number

NO983617A

Other languages

English (en)

Norwegian (no)

Other versions

NO983617D0 (no

Inventor

Bernard Rentier

Catherine Sadzot

Original Assignee

Smithkline Beecham Biolog

Univ Liege

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-02-09

Filing date

1998-08-06

Publication date

1998-10-02

1996-02-09 Priority claimed from GBGB9602617.4A external-priority patent/GB9602617D0/en

1996-12-24 Priority claimed from GBGB9626882.6A external-priority patent/GB9626882D0/en

1998-08-06 Application filed by Smithkline Beecham Biolog, Univ Liege filed Critical Smithkline Beecham Biolog

1998-08-06 Publication of NO983617D0 publication Critical patent/NO983617D0/no

1998-10-02 Publication of NO983617L publication Critical patent/NO983617L/no

Links

241000701085 Human alphaherpesvirus 3 Species 0.000 title 1
108090000623 proteins and genes Proteins 0.000 title 1
229960005486 vaccine Drugs 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/245—Herpetoviridae, e.g. herpes simplex virus
- A61K39/25—Varicella-zoster virus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
- C12N2710/16722—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
- C12N2710/16734—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Virology (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Immunology (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Organic Chemistry (AREA)
Mycology (AREA)
Microbiology (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Epidemiology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Engineering & Computer Science (AREA)
Molecular Biology (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Biotechnology (AREA)
Gastroenterology & Hepatology (AREA)
Biochemistry (AREA)
Biophysics (AREA)
Genetics & Genomics (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Bioinformatics & Cheminformatics (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Peptides Or Proteins (AREA)

NO983617A 1996-02-09 1998-08-06 Vaksine mot Varicella Zoster virusgen 63 produkt NO983617L (no)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
GBGB9602617.4A GB9602617D0 (en)	1996-02-09	1996-02-09	Vaccines
GBGB9626882.6A GB9626882D0 (en)	1996-12-24	1996-12-24	Vaccines
PCT/EP1997/000520 WO1997028820A1 (en)	1996-02-09	1997-02-04	Vaccines against varicella zoster virus gene 63 product

Publications (2)

Publication Number	Publication Date
NO983617D0 NO983617D0 (no)	1998-08-06
NO983617L true NO983617L (no)	1998-10-02

Family

ID=26308641

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO983617A NO983617L (no)	1996-02-09	1998-08-06	Vaksine mot Varicella Zoster virusgen 63 produkt

Country Status (20)

Country	Link
EP (1)	EP0879060B1 (cs)
JP (1)	JP2002504080A (cs)
KR (1)	KR100365986B1 (cs)
CN (1)	CN1210470A (cs)
AR (1)	AR005750A1 (cs)
AT (1)	ATE390146T1 (cs)
AU (1)	AU723555B2 (cs)
BR (1)	BR9707400A (cs)
CA (1)	CA2245545C (cs)
CZ (1)	CZ289971B6 (cs)
DE (1)	DE69738597T2 (cs)
ES (1)	ES2301175T3 (cs)
HU (1)	HUP0001991A3 (cs)
IL (1)	IL125440A (cs)
NO (1)	NO983617L (cs)
NZ (1)	NZ331164A (cs)
PL (1)	PL188457B1 (cs)
TR (1)	TR199801531T2 (cs)
TW (1)	TW575427B (cs)
WO (1)	WO1997028820A1 (cs)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU1145699A (en)	1997-09-05	1999-03-22	Smithkline Beecham Biologicals (Sa)	Oil in water emulsions containing saponins
NZ506602A (en) *	1998-03-09	2003-02-28	Smithkline Beecham Biolog S	Combined vaccine compositions against hepatitis B virus and herpes simplex virus and possibly also epstein bar virus, hepatitis A & C viruses, human papilloma virus, varicella zoster virus, human cytomegalovirus, and toxoplasma gondii
GB9901254D0 (en) *	1999-01-20	1999-03-10	Smithkline Beecham Biolog	Vaccines
GB9921146D0 (en) *	1999-09-07	1999-11-10	Smithkline Beecham Biolog	Novel composition
CN100333794C (zh) *	1999-11-03	2007-08-29	宝德杰克特疫苗有限公司	佐剂化的基因疫苗
IL151097A0 (en)	2000-02-23	2003-04-10	Smithkline Beecham Biolog	Tumour-specific animal proteins
MX2011012623A (es)	2009-05-27	2011-12-14	Glaxosmithkline Biolog Sa	Construcciones de casb7439.
US11576958B2 (en)	2013-02-07	2023-02-14	Children's Medical Center Corporation	Protein antigens that provide protection against pneumococcal colonization and/or disease
KR101723605B1 (ko) *	2014-10-21	2017-04-07	진원생명과학 주식회사	대상포진 예방 및 치료용 dna 백신 조성물 및 이를 이용한 vzv 항원에 대한 t세포 활성화 방법
MX2024002779A (es)	2021-09-09	2024-06-11	Affinivax Inc	Vacunas neumocócicas multivalentes.
CN117224664B (zh) *	2023-10-23	2024-05-24	简达生物医药(南京)有限公司	一种重组带状疱疹疫苗注射液及其制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4952674A (en) *	1986-05-02	1990-08-28	Merck & Co., Inc.	Vaccine against varicella-zoster virus
DE69017769T2 (de) *	1989-06-27	1995-07-13	Smithkline Beecham Biologicals S.A., Rixensart	Verbindungen.

1997
- 1997-02-04 KR KR10-1998-0706090A patent/KR100365986B1/ko not_active Expired - Fee Related
- 1997-02-04 AT AT97902334T patent/ATE390146T1/de not_active IP Right Cessation
- 1997-02-04 TR TR1998/01531T patent/TR199801531T2/xx unknown
- 1997-02-04 WO PCT/EP1997/000520 patent/WO1997028820A1/en not_active Ceased
- 1997-02-04 BR BR9707400-4A patent/BR9707400A/pt not_active Application Discontinuation
- 1997-02-04 CZ CZ19982486A patent/CZ289971B6/cs not_active IP Right Cessation
- 1997-02-04 EP EP97902334A patent/EP0879060B1/en not_active Expired - Lifetime
- 1997-02-04 PL PL97328414A patent/PL188457B1/pl not_active IP Right Cessation
- 1997-02-04 CN CN97192099A patent/CN1210470A/zh active Pending
- 1997-02-04 NZ NZ331164A patent/NZ331164A/en unknown
- 1997-02-04 DE DE69738597T patent/DE69738597T2/de not_active Expired - Fee Related
- 1997-02-04 CA CA002245545A patent/CA2245545C/en not_active Expired - Fee Related
- 1997-02-04 IL IL12544097A patent/IL125440A/en not_active IP Right Cessation
- 1997-02-04 AU AU16012/97A patent/AU723555B2/en not_active Ceased
- 1997-02-04 ES ES97902334T patent/ES2301175T3/es not_active Expired - Lifetime
- 1997-02-04 HU HU0001991A patent/HUP0001991A3/hu not_active Application Discontinuation
- 1997-02-04 JP JP52814197A patent/JP2002504080A/ja active Pending
- 1997-02-07 AR ARP970100494A patent/AR005750A1/es not_active Application Discontinuation
- 1997-06-25 TW TW086102043A patent/TW575427B/zh not_active IP Right Cessation
1998
- 1998-08-06 NO NO983617A patent/NO983617L/no unknown

Also Published As

Publication number	Publication date
AU723555B2 (en)	2000-08-31
NO983617D0 (no)	1998-08-06
IL125440A0 (en)	1999-03-12
ES2301175T3 (es)	2008-06-16
DE69738597T2 (de)	2008-07-24
CN1210470A (zh)	1999-03-10
NZ331164A (en)	2000-02-28
EP0879060B1 (en)	2008-03-26
KR19990082360A (ko)	1999-11-25
DE69738597D1 (de)	2008-05-08
CZ248698A3 (cs)	1998-12-16
HUP0001991A3 (en)	2003-08-28
TW575427B (en)	2004-02-11
BR9707400A (pt)	2000-01-04
WO1997028820A1 (en)	1997-08-14
HUP0001991A2 (hu)	2000-10-28
PL328414A1 (en)	1999-01-18
KR100365986B1 (ko)	2003-02-20
EP0879060A1 (en)	1998-11-25
JP2002504080A (ja)	2002-02-05
AR005750A1 (es)	1999-07-14
CZ289971B6 (cs)	2002-05-15
ATE390146T1 (de)	2008-04-15
IL125440A (en)	2002-02-10
CA2245545A1 (en)	1997-08-14
AU1601297A (en)	1997-08-28
CA2245545C (en)	2008-12-30
TR199801531T2 (xx)	1998-10-21
PL188457B1 (pl)	2005-02-28

Publication	Publication Date	Title
FI923707A7 (fi)	1992-08-18	Oligonukleotidterapier foer modulering av effekten hos herpesvirus
ZA945414B (en)	1995-03-01	DNA virus ribozymes
NO976060D0 (no)	1997-12-23	Vaksiner mot hepatitt C
DE69300550D1 (de)	1995-11-02	Motorisch angetriebenes Klammergerät.
FI954329A0 (fi)	1995-09-14	Farmaseuttisina aineina käytettäviä nukleiinihappoja
ATE209045T1 (de)	2001-12-15	Hepatitis b impfstoff
FI934295L (fi)	1994-03-31	Boggi foer jaernvaegsfordon med variabel spalt mellan hjul
FI953079L (fi)	1995-06-21	DNA:n vahvistaminen
DE69405605D1 (de)	1997-10-23	Motorisch angetriebenes Klammergerät
DE69426294D1 (de)	2000-12-21	Rehydrierbares produkt
NO983617L (no)	1998-10-02	Vaksine mot Varicella Zoster virusgen 63 produkt
DE69606124D1 (de)	2000-02-17	Abfallblasgerät
AU3900893A (en)	1993-11-18	Quantitative viral assay
IS4629A (is)	1997-12-05	Samskeyttar veirukjarnsýrur
FR11C0050I2 (fr)	2012-06-22	Virus myxomateux recombinant
ATE240392T1 (de)	2003-05-15	Spezifische oligonukleotide fuer hepatitis c- virus
ITMI932517A0 (it)	1993-11-30	Cassa di soffiante
FI973448A0 (fi)	1997-08-22	Liukulevy
ES1027324Y (es)	1995-02-16	Soplador
AU7336296A (en)	1997-05-22	Human hepatitis b virus dna
KR950702244A (ko)	1995-06-19	백신으로서의 즉석 초기 hsv-2 비루스 단백질 icp27(immediatie early hsv-2 viral protein icp27 as vaccine)
HK1016474A (en)	1999-11-05	Vaccines against varicella zoster virus gene 63 product
KR970021240U (ko)	1997-06-18	진공발포기
DE69402721D1 (de)	1997-05-22	Markraumnagelsystem
NO933907L (no)	1995-05-22	Syklonsystem